Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Colin Eldred is active.

Publication


Featured researches published by Colin Eldred.


Tetrahedron Letters | 2002

An efficient method for the synthesis of N,N′-dimethyl-1,2-diamines

Heather Tye; Colin Eldred; Martin Wills

Abstract A simple method for the preparation of N,N′-dimethyl-1,2-diamines is described. The method requires the dimethylation of a diazaphospholidine oxide followed by acid-catalysed hydrolysis.


Progress in Medicinal Chemistry | 1999

Fibrinogen receptor antagonists : Design and clinical applications

Colin Eldred; Brian David Judkins

Publisher Summary This chapter discusses the design and clinical applications of fibrinogen receptor antagonists. The concept of a fibrinogen receptor antagonist as a powerful new antithrombotic mechanism arose from consideration of the central role of the platelet in thrombosis. In healthy blood vessels, “resting” platelets do not adhere to the nonthrombogenic surface of intact endothelium. However, platelets can adhere to subendothelial structures of a damaged vessel wall, for example, following rupture of an atherosclerotic plaque, resulting in initiation of the process of clot formation. The fibrinogen receptor represents the best characterized member of the integrin family of cell adhesion receptors, which are involved in a wide variety of cell–cell and cell-extracellular matrix interactions. The pharmacodynamic duration of action of fibrinogen antagonists has generally been assessed by measuring inhibition of platelet aggregation ex vivo in samples of blood taken at intervals following i.v. or p.o. administration of drug, for example in the marmoset. The most common approach used to increase bioavailability of fibrinogen antagonists is to mask one or both of the charged entities thereby increasing log D and increasing the likelihood of absorption through lipophilic membranes. In addition to studying the ability of fibrinogen antagonists to prevent thrombus formation, the ability of these agents to enhance the outcome of thrombolytic therapy has been studied in several animal models, in which thrombolysis alone is only partially effective and/or is followed by rapid reocclusion.


Journal of The Chemical Society-perkin Transactions 1 | 2001

Synthesis and applications to asymmetric catalysis of a series of mono- and bis(diazaphospholidine) ligands

Donald Smyth; Heather Tye; Colin Eldred; Nathaniel W. Alcock; Martin Wills

The synthesis of a series of closely related mono- and bis(diazaphospholidine) ligands has been achieved using the condensation of a diamine with a bis(dimethylamino)arylphosphine. The resulting ligands have given excellent results in palladium-catalysed allylic substitution reactions to form C–C bonds (up to 89% ee) and C–N bonds (up to 78% ee).


Journal of The Chemical Society-perkin Transactions 1 | 1998

Design, synthesis and preliminary studies on a novel class of chiral receptor for the recognition of amino acid derivatives1

Heather Tye; Colin Eldred; Martin Wills

The design and synthesis of a novel class of chiral receptor for the recognition of amino acid derivatives is described. Moderate enantioselectivity is observed in binding experiments.


Chemical Communications | 1997

Synthesis and applications of a new class of phosphorus donorligands for asymmetric catalysis

Heather Tye; Donald Smyth; Colin Eldred; Martin Wills

The synthesis and applications to allylic substitutions of a range of novel ligands based on diazaphospholidines is described; enantiomeric excesses of up to 89% were achieved in an allylic substitution reaction.


Chemical Communications | 1997

Synthesis and applications of a new class of phosphorus donor ligands for asymmetric catalysis

Heather Tye; Donald Smyth; Colin Eldred; Martin Wills


Archive | 1997

Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders

David George Allen; Colin Eldred; Brian David Judkins; William Leonard Mitchell; David Ian Carter Scopes


Archive | 1993

1-piperazineacetic derivatives as fibrinogen receptor antagonists

David Middlemiss; Brian David Judkins; Colin Eldred; Barry Porter; Henry Anderson Kelly


Archive | 2002

Adenosine derivatives and methods of administration

David Edmund Bays; Richard Peter Charles Cousins; Hazel Joan Dyke; Colin Eldred; Brian David Judkins; Martin Pass; Andrew Michael Kenneth Pennell


Synlett | 1995

The Synthesis of a Synthetic Receptor via Directed Lithiations of Dibenzofuran and Bibenzothiophene

Heather Tye; Colin Eldred; Martin Wills

Collaboration


Dive into the Colin Eldred's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Middlemiss

University of Hertfordshire

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge